GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
AO GENERIUM
AO GENERIUM
Gadjah Mada University
The First Affiliated Hospital with Nanjing Medical University
TYK Medicines, Inc
Hellenic Society of Hematology
OncoResponse, Inc.
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Fujian Medical University
QureBio Ltd.
Kineta Inc.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Shandong Cancer Hospital and Institute
Mansoura University
National University Hospital, Singapore
National University Hospital, Singapore
LaSanta S A S
Glycostem Therapeutics BV
Scandion Oncology A/S
Tarveda Therapeutics
Taiga Biotechnologies, Inc.
Scandion Oncology A/S
Waterford Instituate of Technology
Beijing Immunochina Medical Science & Technology Co., Ltd.
Shenzhen University General Hospital
Accendatech USA Inc.
Royal Marsden NHS Foundation Trust
ImmunoVaccine Technologies, Inc. (IMV Inc.)
University Hospital Tuebingen
Butantan Institute
Shenzhen University General Hospital
Vietlife Healthcare Corporation
Hamlet Pharma AB
Shenzhen Geno-Immune Medical Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Acibadem University
Sichuan Cancer Hospital and Research Institute
Shenzhen Geno-Immune Medical Institute
Radboud University Medical Center
Asclepius Technology Company Group (Suzhou) Co., Ltd.
Clinica Universidad de Navarra, Universidad de Navarra
Shenzhen Geno-Immune Medical Institute
Hadassah Medical Organization
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Zhejiang University
East and North Hertfordshire NHS Trust
LondonPharma Ltd.
Arno Therapeutics
Hanmi Pharmaceutical Company Limited
Jichi Medical University